The human brain has long been regarded as one of the most versatile parts of the body due to neuroplasticity. This is basically the concept where people can change the properties of their gray matter by introducing particular stimuli. In recent research papers, scientists are seeing indications that meditating can lead to a brain that is decades younger than the body and a heightened level of selflessness.
As Futurism notes, there have been numerous studies related to the effects of meditation on neuroplasticity. One of these is the Johns Hopkins School of Public Health study that found how meditation can help decrease anxiety and depression just as well as drugs.
There are also studies that note how meditation can affect certain parts of the brain in order to make them seem younger. There were even cases where patients 50 years of age had similar gray matter levels to those 25 years their junior. One of the biggest benefits to this kind of result includes the prevention of dementia or some other type of neurological degradation.
With regards to the psychological effects of meditation, it has long been accepted that the practice is meant to encourage peace of mind. However, a Yale study also discovered that it can make people less selfish. The study also found that it helped to increase concentration as well as to be more considerate of others.
Even overcoming smoking addiction has been the subject of research involving meditation, with some cases reporting success rates of 60 percent. The same goes for cases where self-control is an issue, so it basically applies to pretty much any kind of addiction.
All in all, numerous scientific literature are now suggesting that meditation is a solution to many of the problems that people often address via drugs or some other form of addictive activity. Heck, it can even supplant exercise, though, it’s always best to combine both.


Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
The four types of dementia most people don’t know exist
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
Is dark chocolate healthier than milk chocolate? 2 dietitians explain
Why the future of marijuana legalization remains hazy despite high public support 



